BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 838211)

  • 1. Antibody to hepatitis B core antigen in chronic hepatitis and primary biliary cirrhosis: evaluation by a new autologous solid phase radioimmunoassay.
    Grady GF; Kaplan MM; Vyas GN
    Gastroenterology; 1977 Apr; 72(4 Pt 1):590-3. PubMed ID: 838211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antinuclear antibody (anti-HBc) and liver pathology in acute and chronic virus B hepatitis].
    Dentico P; Pastore G; Buongiorno R; Angarano G; Lapedota E; Schiraldi O
    Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1141-6. PubMed ID: 317942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-core antibody in HBsAg negative subjects].
    Ferroni P; Quartodipalo ME; Zanetti AR
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):676-9. PubMed ID: 556542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay detection of IgM antibodies to the hepatitis B core antigen in HBsAg liver disease.
    Lavarini C; Crivelli O; Smedile A; Farci P; Marinucci G; Muglia M; Rizzetto M
    Boll Ist Sieroter Milan; 1982; 61(3):210-7. PubMed ID: 6985422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-HBc within the framework of hepatitis B virus infection: correlation to the form of inflammation and to the viral expression].
    Endo Y; Gudat F; Bianchi L; Mihatsch M; Gasser M; Stalder GA; Schmid M
    Schweiz Med Wochenschr; 1978 Mar; 108(10):363-73. PubMed ID: 625636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
    J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection.
    Tsuda F; Naito S; Takai E; Akahane Y; Furuta S; Miyakawa Y; Mayumi M
    Gastroenterology; 1984 Jul; 87(1):159-64. PubMed ID: 6724259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunology of liver diseases].
    Meyer zum Büschenfelde KH
    Schweiz Med Wochenschr; 1987 Jul; 117(29):1065-75. PubMed ID: 3313682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High titre of antibody to hepatitis B core antigen detected by immune adherence haemagglutination in HBsAg-positive acute hepatitis.
    Ikegami F; Takasu S; Jo K; Miyakawa Y; Tsuda F; Mayumi M
    Hepatogastroenterology; 1982 Aug; 29(4):142-3. PubMed ID: 7129336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of antibody to hepatitis B core antigen by radioimmunoassay in chronic liver disease.
    Mizuno M; Yamada G; Sakamoto Y; Yumoto Y; Nagashima H
    Acta Med Okayama; 1980 Jun; 34(3):155-60. PubMed ID: 6251699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Boczanowski M; Gerwin R; Corcoran CP; Szczepiorkowski Z; Toner S; Cohen DE; Sax PE; Ukomadu C
    Clin Infect Dis; 2003 Jun; 36(12):1602-5. PubMed ID: 12802762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.